A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease

Numerous clinical trials of drug candidates for Alzheimer’s disease (AD) have failed, and computational drug repositioning approaches using omics data have been proposed as effective alternative approaches to the discovery of drug candidates. However, little multi-omics data is available for AD, due...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Soo Youn Lee, Min-Young Song, Dain Kim, Chaewon Park, Da Kyeong Park, Dong Geun Kim, Jong Shin Yoo, Young Hye Kim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-01-01
coleção:	Frontiers in Pharmacology
Assuntos:	drug repositioning Alzheimer disease proteotranscriptomics transcriptomics proteomics computational drug repositioning
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fphar.2019.01653/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!